Literature DB >> 10602110

Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites.

K D Wenstrom1, G L Johanning, J Owen, K E Johnston, S Acton, S Cliver, T Tamura.   

Abstract

A specific gene mutation leading to altered homocysteine metabolism has been identified in parents and fetuses with neural tube defects (NTDs). In addition, current animal and human data indicate that spine closure occurs simultaneously in five separate sites that then fuse. We sought to determine whether either this mutation or abnormal amniotic fluid homocysteine levels are associated with all five neural tube closure sites. We retrieved stored amniotic fluid from cases of isolated fetal neural tube defect diagnosed from 1988 to 1998 (n = 80) and from normal controls matched for race, month and year of amniocentesis, and maternal age. Cases were categorized according to defect site by using all available medical records. The presence or absence of the 677C-->T mutation of 5, 10-methylenetetrahydrafolate reductase (MTHFR) gene was determined, and homocysteine levels were measured; case and controls were compared. Significantly more cases than controls were heterozygous or homozygous for the 677C-->T MTHFR mutation (44% vs. 17%, P < or = 0. 001). Likewise, cases were significantly more likely than controls to have amniotic fluid homocysteine levels >90th centile (>1.85 micromol/L), 27% vs. 10%, P = 0.02. Most (83%) of control cases had both normal MTHFR alleles and normal amniotic fluid homocysteine levels (normal/normal), whereas only 56% of NTD case were normal/normal (P = 0.001). When evaluated by defect site, only defects involving the cervical-lumbar spine, lumbosacral spine, and occipital encephalocele were significantly less likely to be normal/normal than controls (P = 0.007, 0.0003, and 0.007, respectively), suggesting a strong association with the 677C-->T allele. In contrast, anencephaly, exencephaly, and defects confined to the sacrum included many cases that had both normal MTHFR alleles and normal homocysteine and were not significantly different from controls. The 677C-->T MTHFR mutation and elevated homocysteine levels appear to be disproportionately associated with defects spanning the cervical-lumbar spine, lumbosacral spine, and occipital encephalocele. In contrast, anencephaly, exencephaly, and defects confined to the sacrum may not be related to altered homocysteine metabolism. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602110     DOI: 10.1002/(sici)1096-8628(20000103)90:1<6::aid-ajmg2>3.0.co;2-h

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

Review 1.  Genetics of homocysteine metabolism and associated disorders.

Authors:  S Brustolin; R Giugliani; T M Félix
Journal:  Braz J Med Biol Res       Date:  2009-12-04       Impact factor: 2.590

2.  Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome.

Authors:  Mert Turgal; Fatma Gumruk; Ergun Karaagaoglu; Mehmet Sinan Beksac
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-09-14       Impact factor: 2.915

3.  Study of C677T Methylene Tetrahydrofolate Reductase Gene Polymorphism as a Risk Factor for Neural Tube Defects.

Authors:  Anjalika Goyal; Manjulata Kumawat; Minakshi Vashisth; Paramjit Singh Gill; Ishwar Sing; Dhara B Dhaulakhandi
Journal:  Asian J Neurosurg       Date:  2021-09-14

Review 4.  Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications.

Authors:  Henrik Zetterberg
Journal:  Reprod Biol Endocrinol       Date:  2004-02-17       Impact factor: 5.211

Review 5.  Neural tube defects, folic acid and methylation.

Authors:  Apolline Imbard; Jean-François Benoist; Henk J Blom
Journal:  Int J Environ Res Public Health       Date:  2013-09-17       Impact factor: 3.390

6.  Analysis of MTR and MTRR Polymorphisms for Neural Tube Defects Risk Association.

Authors:  Yongxin Wang; Yuan Liu; Wenyu Ji; Hu Qin; Hao Wu; Danshu Xu; Turtuohut Tukebai; Zengliang Wang
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.